arrow
D

Douglas W. Losordo

University of Toledo
H指数:99
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Path Forward for Regenerative Medicine: Navigating Regulatory Challenges: Summary of Findings From the Cardiac Safety Research Consortium/Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine
2018-08-035
OAAI
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials

自体CD34细胞疗法可改善无可选性难治性心绞痛的运动能力,心绞痛频率并降低死亡率: 对随机双盲试验的患者水平汇总分析

2018-01-0575
OAAI
Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
2017-07-229
PREAI
Global position paper on cardiovascular regenerative medicine
2017-05-30123
OAAI
PreSERVE-AMI A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+Cells in Patients With Left Ventricular Dysfunction Post STEMI
2017-01-20113
OAAI
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study
2016-09-0155
OAAI
The RENEW Trial Efficacy and Safety of Intramyocardial Autologous CD34+ cell Administration in Patients With Refractory Angina

难治性心绞痛患者心肌内自体CD34细胞给药的有效性和安全性的RENEW试验

2016-08-01103
OAAI